Why the study?
Does an initially invasive strategy improve angina-related health status in participants with stable ischemic heart disease, moderate or severe ischemia, and advanced chronic kidney disease?
Does an initially invasive strategy improve angina-related health status in participants with stable ischemic heart disease, moderate or severe ischemia, and advanced chronic kidney disease?
An initially invasive strategy does not provide substantial or sustained benefits in angina-related health status compared to a conservative strategy in patients with stable ischemic heart disease and advanced CKD.
Answers are grounded in this paper and cite their sources.
Supports conservative strategy for angina in advanced CKD; extends evidence against routine invasive approach in this population.
Participants with stable ischemic heart disease, moderate or severe ischemia, and advanced chronic kidney disease did not have substantial or sustained benefits with regard to angina-related health status with an initially invasive strategy as compared with a conservative strategy. (Funded by the National Heart, Lung, and Blood Institute; ISCHEMIA-CKD ClinicalTrials.gov number, NCT01985360.).
No takes yet. Share an insight, caveat, or question.
Spertus et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: